Previous investigations demonstrated that those functional genetic variations of Fas/FasL/CASP8 may influence the susceptibility to gastric cancer or affected the sensitivity to platinum-based chemotherapy for some types of cancer, including non-small-cell lung cancer, malignant pleural mesothelioma and so on 29-31. The gene discussed is FAS; the disease is cancer.